نتایج جستجو برای: antileukemic activity

تعداد نتایج: 1134946  

Journal: :Synthesis 2021

Abstract A new method for the fast synthesis of diverse 4-aryl-6-cycloamino-1,3,5-triazin-2-amines was developed. The is performed under microwave irradiation in a one-pot manner from cyanoguanidine, aromatic aldehydes, and cyclic amines. Their three-component reaction presence hydrochloric acid produced dihydrotriazines, which were then converted (without isolation) into targeted compounds via...

Journal: :Cancer research 1968
E J Blanz F A French

5 -Hydroxy-2-formylpyridine thiosemicarbazone (5-HP) is highly active intraperitoneally against leukemia L-1210, Ehrlich ascites carcinoma, and lymphoma L-5 178Y over a broad dose range. 5-HP is also active on leukemia L-l210 and the Ehrlich ascites carcinoma by delayed treatment. Activity by oral routes or subcutaneously is poor. Moderate activity is displayed against the Lewis lung carcinoma ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Xiaomeng Huang Sebastian Schwind Bo Yu Ramasamy Santhanam Hongyan Wang Pia Hoellerbauer Alice Mims Rebecca Klisovic Alison R Walker Kenneth K Chan William Blum Danilo Perrotti John C Byrd Clara D Bloomfield Michael A Caligiuri Robert J Lee Ramiro Garzon Natarajan Muthusamy Ly James Lee Guido Marcucci

PURPOSE miR-29b directly or indirectly targets genes involved in acute myeloid leukemia (AML), namely, DNMTs, CDK6, SP1, KIT, and FLT3. Higher miR-29b pretreatment expression is associated with improved response to decitabine and better outcome in AML. Thus, designing a strategy to increase miR-29b levels in AML blasts may be of therapeutic value. However, free synthetic miRs are easily degrade...

Journal: :Haematologica 2011
Benoist Pruvot Arnaud Jacquel Nathalie Droin Patrick Auberger Didier Bouscary Jérome Tamburini Marc Muller Michaela Fontenay Johanna Chluba Eric Solary

Zebrafish were proposed as an alternative to mammalian models to assess the efficacy and toxicity of antileukemic drugs. Due to the limited number of transgenic zebrafish leukemia models, we explored human leukemic cell xenograft in zebrafish embryos. Human leukemic cell lines and blast cells sorted from patients with acute myelogenous leukemia were injected 48 hours post-fertilization and rema...

2013
Armen Mardiros Christine E Brown L Elizabeth Budde Xiuli Wang Stephen J Forman

Acute myeloid leukemia remains a difficult disease to cure and novel therapeutic approaches are needed. To this end, we developed CD123 chimeric antigen receptor (CAR) redirected T cells which exhibited potent antileukemic activity. We discuss what we learned during the development of CD123 CARs and future directions for this immunotherapy.

Journal: :Cancer research 1976
J H Burchenal K Ciovacco K Kalaher T O'Toole R Kiefner M D Dowling C K Chu K A Watanabe I Wempen J J Fox

Pseudoisocytidine, a new synthetic pyrimidine C-nucleoside, which might be considered a more stable analog of 5-azacytidine, is active in vitro and in vivo, i.p. and p.o., against various 1-beta-D-arabinofuranosylcytosine-resistant lines of mouse leukemia. This antileukemic activity is blocked by cytidine but not by deoxycytidine or thymidine.

2017
Jun Ma Xinyu Li Yongwei Su Jianyun Zhao Daniel A. Luedtke Valeria Epshteyn Holly Edwards Guan Wang Zhihong Wang Roland Chu Jeffrey W. Taub Hai Lin Yue Wang Yubin Ge

Acute myeloid leukemia (AML) continues to be a challenging disease to treat, thus new treatment strategies are needed. In this study, we investigated the antileukemic effects of ATR inhibition alone or combined with cytarabine in AML cells. Treatment with the ATR-selective inhibitor AZ20 caused proliferation inhibition in AML cell lines and primary patient samples. It partially abolished the G2...

2006
Erwin J. Blanz Frederic A. French

5 -Hydroxy-2-formylpyridine thiosemicarbazone (5-HP) is highly active intraperitoneally against leukemia L-1210, Ehrlich ascites carcinoma, and lymphoma L-5 178Y over a broad dose range. 5-HP is also active on leukemia L-l210 and the Ehrlich ascites carcinoma by delayed treatment. Activity by oral routes or subcutaneously is poor. Moderate activity is displayed against the Lewis lung carcinoma ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید